Leucovorin Rescue Allows Effective High-Dose Pralatrexate Treatment and an Increase in Therapeutic Index in Mesothelioma Xenografts

Cancer Chemotherapy and Pharmacology - Germany
doi 10.1007/s00280-014-2580-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Changes in Intracellular Folate Metabolism During High-Dose Methotrexate and Leucovorin Rescue Therapy in Children With Acute Lymphoblastic Leukemia

PLoS ONE
Multidisciplinary
2019English

Preemptive Leucovorin Administration Minimizes Pralatrexate Toxicity Without Sacrificing Efficacy

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2013English

Tomotherapy After Pleurectomy/Decortication or Biopsy for Malignant Pleural Mesothelioma Allows the Delivery of High Dose of Radiation in Patients With Intact Lung

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2012English

ECMO as an Effective Rescue Therapeutic for Fulminant Myocarditis Complicated With Refractory Cardiac Arrest

Therapeutics and Clinical Risk Management
2017English

High-Dose Palliative Radiotherapy for Malignant Pleural Mesothelioma

Journal of Medical Imaging and Radiation Oncology
OncologyRadiologyNuclear MedicineImaging
2017English

Treatment of Poor-Risk Neuroblastoma Patients With High-Dose Chemotherapy and Autologous Peripheral Stem Cell Rescue

Bone Marrow Transplantation
TransplantationHematology
1997English

High-Dose Cyclophosphamide Without Stem Cell Rescue in Immune-Mediated Necrotizing Myopathies

Neurology: Neuroimmunology and NeuroInflammation
Neurology
2017English

658 Low-Dose CCL2 Allows the Rescue of Maternal Delayed Healing Through Fetal Progenitor Cells Recruitment

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2017English

Carboxypeptidase-G2 Rescue in a Patient With High Dose Methotrexate-Induced Nephrotoxicity

Cancer Research and Treatment
Cancer ResearchOncology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy